CD8A and esophageal squamous cell carcinoma: CD8 T cells and DCs were found to be altered between the subtypes (Supplementary Figures 5, 12, 13), suggesting that adoptive DC therapy or T-cell therapy could have an advantageous role in ESCC treatment.